During the current pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (Covid-19), has diversified considerably. As of September ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic surveillance continues to reveal a varied spectrum of novel variations with mutations in the spike gene, which encodes the ...
A fast, effective, reliable, and low-cost new technology aimed at quantifying SARS-CoV-2 neutralising antibodies in the blood, but also at testing the efficacy of new vaccines against COVID-19. The ...
Evaluating an individual’s immunity to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19), is required because vaccine ...
Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern pose a challenge to the effectiveness of current vaccines. A vaccine that could prevent infection caused by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results